Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    XXETR:GBY
    - -
    EUR
    - -
    - -
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    0.2
    0.41
    0.43
    0.68
    0.57
    0.27
    0.47
    0.87
    0.91
    0.88
    0.77
    - -
    - -
    - -
    Basic EPS, GAAP
    -0.71
    -0.42
    -0.48
    -0.39
    -0.58
    -1.02
    -0.7
    -0.7
    -0.85
    -0.9
    -1.23
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    -0.52
    -0.17
    -0.36
    -0.08
    -0.48
    -0.94
    0.1
    -0.07
    -1.47
    1.15
    -1.77
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -5
    -5.21
    -5.39
    -4.89
    -5.28
    -6.24
    -6.33
    -5.79
    -5.85
    -5.78
    -6.6
    - -
    - -
    - -
    Tangible Book Value per Share
    1.59
    1.23
    2.11
    3.03
    2.74
    1.91
    2.39
    2.82
    3.04
    2.95
    1.95
    - -
    - -
    - -
    Basic Weighted Avg Shares
    51
    53
    56
    67
    70
    71
    78
    97
    112
    134
    145
    - -
    - -
    - -
    Sales/Revenue/Turnover
    10
    22
    24
    46
    40
    19
    37
    84
    102
    118
    111
    111
    176
    12
    Operating Margin (%)
    -347.14
    -102.51
    -110.66
    -58.38
    -118.51
    -374.23
    -154.13
    -91.35
    -102.69
    -109.61
    -165.61
    -180.85
    -67.52
    -1,681.69
    Depreciation Expense
    1
    1
    1
    1
    1
    1
    1
    2
    10
    13
    18
    21
    22
    16
    Net Income, GAAP
    -36
    -22
    -27
    -26
    -41
    -72
    -55
    -68
    -95
    -121
    -178
    -192
    -258
    -250
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -346.45
    -102.81
    -110.32
    -57.59
    -102.94
    -369.58
    -149.23
    -80.91
    -92.93
    -102.37
    -161.05
    -172.76
    -146.3
    -2,033.68
    Working Capital
    78
    60
    87
    170
    192
    136
    204
    332
    336
    516
    271
    189
    47
    1
    LT Debt
    - -
    - -
    - -
    - -
    - -
    4
    25
    28
    41
    38
    44
    39
    34
    29
    Total Equity
    80
    65
    122
    207
    192
    136
    188
    367
    433
    497
    375
    295
    83
    24
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    5
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    34
    31
    29
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    178
    204
    208
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    94
    69
    40
    Cash, Cash Equivalents & STI
    81
    54
    28
    Accounts Receivable, Net
    1
    1
    1
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    48
    40
    39
    Payables & Accruals
    34
    34
    33
    ST Debt
    5
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.2%
    -17.02%
    -71.9%
    Free Cash Flow
    219.18%
    394.08%
    0.9%
    Net Income, GAAP
    28.64%
    31.14%
    34.09%
    Sales/Revenue/Turnover
    33.41%
    17.84%
    58.34%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    28
    29
    26
    27
    111
    2023
    158
    7
    9
    2
    176
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.3
    -0.29
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business